LEO 6. Ferumoxytol-Enhanced Magnetic Resonance Angiography —Clinical Feasibility and Optimal Dosing

Traditional contrast media are problematic in advanced chronic kidney disease. Ultrasmall superparamagnetic particles of iron oxide (ferumoxytol) are safe in chronic kidney disease and have been used for imaging in other settings. We tested the feasibility of ferumoxytol-enhanced magnetic resonance angiography (FeMRA) in patients with renal failure and performed a dose-finding study.

Source: Journal of Vascular Surgery - October 22, 2018 Category: Surgery Authors: Alex Vesey, Martin Hennessy, Sokratis Stoumpos, Aleksandra Radjenovic, David Kingsmore, Patrick Mark, Giles Roditi Source Type: research